Overview Pembrolizumab (Keytruda): CADTH Reimbursement Advice: Indicator: Together with chemotherapy, for the remedy of adult individuals with locally recurrent unresectable or metastatic triple-damaging breast cancer who've not obtained prior chemotherapy for metastatic condition and whose tumours Specific programmed mobile Dying-ligand one (blended optimistic score ≥ 10) as determin... https://alexf678ttt9.glifeblog.com/profile